Meeting with Prof. Hu Shanlian on Position Paper and Health Insurance Policy

2017-11-28 | Shanghai

In the meeting, Xiaochen Ni, GA Coordinator of Pharmaceutical Working Group introduced the recent works of the working group and presented the 2017/2018 Position Paper. Key industry issues such as IP protection, acceleration of clinical trial, registration and approval, dynamic adjustment of NRDL and pricing and reimbursement were discussed.